When Your Brain and Immune System Talk: A New Lens on Mental Health
May 28, 2026
For decades, mental health treatment has focused on brain chemistry. Serotonin, dopamine, norepinephrine: these are the neurotransmitters that antidepressants, mood stabilizers, and anti-anxiety medications are designed to regulate. And for many people, that approach works well.
But it does not work for everyone. Roughly one in three people with depression does not respond to standard treatments. And even among those who do, finding the right medication often involves trial and error over months or years.
A growing body of research suggests there may be a reason for that gap. What if the problem is not only in the brain? What if, for some people, the root of their depression or anxiety is in the immune system?
This is not a theory on the fringes. In 2026, it is one of the most active areas of psychiatric research, and it is changing how clinicians think about mental health.
What the research says
In May 2026, researchers at the University of Bristol and the University of Cambridge published a landmark study in JAMA Psychiatry. They tested a drug called tocilizumab, an anti-inflammatory medication normally used for rheumatoid arthritis in 30 adults with treatment-resistant depression who also showed signs of low-grade inflammation.
The results were striking. In the group that received tocilizumab, 54 percent achieved remission, compared to 31 percent in the placebo group. The number needed to treat was five, meaning for every five patients treated with this approach, one additional person achieved remission, a figure that compares favorably with standard antidepressants.
Tocilizumab works by blocking interleukin-6, or IL-6, an inflammatory protein that the immune system produces. Previous research by the same team had suggested that the IL-6 pathway may be a biological driver of depression in certain patients. This trial was the first to test that idea directly with a targeted immunotherapy approach.
As Dr. Éimear Foley, the lead author, told the University of Bristol: “This moves us closer to more tailored depression care, where treatments are chosen to better fit a person’s biology.”
Separately, researchers at Harvard Medical School and MIT published studies in Cell showing that immune molecules called cytokines, including IL-17A and IL-10, directly influence brain activity in the amygdala, the region responsible for fear and anxiety. Some cytokines increased anxiety-like behavior; others reduced it. The findings help explain why people often experience mood changes during infections or autoimmune flare-ups, and they open the door to entirely new categories of psychiatric treatment.
How inflammation affects the brain
The concept behind this research is called neuroimmunology, or more broadly, psychoneuroimmunology, the study of how the immune system and the nervous system communicate.
Under normal conditions, the brain enjoys a degree of protection from the rest of the body through the blood-brain barrier. But when the immune system detects a threat, whether from infection, injury, chronic stress, or an autoimmune condition, it releases inflammatory molecules called cytokines into the bloodstream. These cytokines can signal the brain to produce what is known as “sickness behavior”: fatigue, social withdrawal, loss of appetite, low motivation, and reduced interest in normally enjoyable activities.
Sound familiar? These symptoms overlap almost completely with depression.
For most people, sickness behavior is temporary. The immune system resolves the threat, inflammation subsides, and mood returns to baseline. But for some, the inflammatory signal does not turn off. Chronic low-grade inflammation keeps the brain in a persistent state of sickness behavior, and that can look a lot like treatment-resistant depression or chronic anxiety.
About one-third of people with depression have elevated inflammatory markers. The emerging view is that for these individuals, standard antidepressants may be treating the wrong target.
The stress connection
Chronic stress is one of the most common drivers of sustained inflammation. When you experience ongoing stress, whether from work, relationships, finances, caregiving, or health concerns, your body produces cortisol and other stress hormones. Over time, this can dysregulate the immune system, leading to a persistent inflammatory state.
This creates a feedback loop. Stress drives inflammation. Inflammation affects mood, energy, sleep, and motivation. Lower mood and energy make it harder to manage stress. And the cycle continues.
Understanding this loop is important because it points to a broader set of tools for managing mental health: tools that go beyond medication alone.
What this means for mental health care
The research does not mean that antidepressants are outdated or that everyone with depression should take an anti-inflammatory drug. The Bristol trial was small with 30 participants, and a larger phase III study is needed before immunotherapy for depression becomes a standard option.
But the findings reinforce something that many clinicians have observed for years: mental health is not separate from physical health. The brain does not exist in a vacuum. It is constantly receiving signals from the immune system, the gut, the endocrine system, and every other part of the body.
This is why whole-person mental health care matters. At BelleVie Wellness Care, psychiatric evaluations consider more than just mood symptoms. Your provider may ask about sleep patterns, diet, energy levels, stress exposure, medical history, medications, and lab markers. These details help build a fuller picture of what may be driving your symptoms.
Lifestyle factors that support immune balance and mood
While the research on immunotherapy for depression is still emerging, there are evidence-based steps that can help calm inflammation and support mental health right now:
Nutrition. Anti-inflammatory dietary patterns, including the Mediterranean diet and DASH diet, have been linked to lower levels of systemic inflammation and better mental health outcomes. Foods rich in omega-3 fatty acids, fiber, antioxidants, and polyphenols support immune balance, while ultra-processed foods and excess sugar can promote inflammation.
Sleep. Poor sleep triggers inflammatory responses in the body. Consistent, restful sleep is one of the most powerful tools for regulating both immune function and mood.
Stress management. Mindfulness, breathwork, therapy, movement, and time in nature all help regulate the stress response and reduce the inflammatory load on the body.
Movement. Regular physical activity has well-documented anti-inflammatory effects, and it is one of the most consistently effective lifestyle interventions for depression and anxiety.
Targeted wellness support. Some patients may benefit from additional support aimed at cellular and immune health, such as IV therapy, NAD+ therapy, or glutathione therapy, all of which support the body’s natural antioxidant and repair systems.
Peptide therapy and the immune-mood connection
One of the more interesting developments in this area is the role of certain peptides in modulating both immune function and cognitive or emotional well-being. Selank and Semax are two peptides that have been studied for their effects on stress resilience, mood balance, and mental clarity. Selank, in particular, has immune-modulating properties. It is derived from tuftsin, a natural immune molecule,and research suggests it may help regulate inflammatory cytokines while also supporting calm focus and reduced anxiety.
These options are not replacements for psychiatric care, but for patients who have been evaluated by a provider, they may offer a complementary approach that bridges the gap between mental health support and cellular wellness.
At BelleVie Wellness Care, peptide therapy is always provider-guided and personalized. Your provider reviews your health history, current medications, symptoms, and goals before any recommendation is made.
Where BelleVie fits in
BelleVie Wellness Care is led by Dr. Andrelle Franck, a double board-certified family and psychiatric mental health nurse practitioner. This dual training matters because it allows care that does not separate the mind from the body.
If you are experiencing depression, anxiety, brain fog, fatigue, or stress that feels harder to manage than it used to, a first visit does not commit you to any particular treatment. It is a conversation. Your provider will ask about your symptoms, health history, sleep, stress, lifestyle, and goals. Together, you will build a plan that makes sense for you.
Depending on your needs, that plan may include mental health support, therapy-informed care and medication management, lab testing through blood work and labs, concierge medicine and wellness, or complementary options like IV therapy, NAD+ therapy, or peptide therapy.
BelleVie Wellness Care can help
BelleVie Wellness Care offers mental health services in Hollywood, Florida, with support for depression, anxiety, stress, ADHD, PTSD, sleep concerns, bipolar disorders, and whole-person wellness. Care is led by a double board-certified provider who treats mental and physical health as deeply connected.
If you have been feeling off and are not sure why, or if standard treatments have not given you the relief you were hoping for, a consultation can help you understand what is going on and find a next step that feels right for you.